New offering provides drug developers with flexible and powerful cell line development options for monoclonal antibodies, multi-specific and complex molecules SEATTLE--(BUSINESS WIRE)-- As drug ...
Client programs using CHOMax follow platform-defined workflows and phase-appropriate practices across the development lifecycle.
Cell line development continues to face technical and operational hurdles in transfection, clone selection, and media optimization. Manual screening, extended culture timelines, and fragmented data ...
Traditional approaches to biologics production—relying on one-size-fits-all expression vectors and empirical process optimization—have led to inefficiencies in expression, scalability, and ...
Cell line creation is a major success factor in biologics manufacturing. It establishes the basis for product yield, quality, and long-term process stability. However, despite significant ...
From Fluidic Sciences and Sphere BioReviewed by Olivia Frost This article is based on a poster originally authored by Maryam Ahmadi, Elena Shvets, Frank Gesellchen, Xin Liu, Jessica Hall and Richard ...
How do you currently identify and select cells for further growth, characterization and processing? Many available cell-selection technologies lack the sensitivity necessary to preserve cell health ...
Successful commercialization of a biopharmaceutical product is dependent upon an effective, high-quality cell-line development process. While high-throughput analytical instruments often take center ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback